(Q34993237)

5 August 2017

1 reference

title

Molecular and biologic basis of upper gastrointestinal malignancy--esophageal carcinoma (English)

1 reference

5 August 2017

Rhonda F Souza

1

1 reference

5 August 2017

1 April 2002

1 reference

Surgical oncology clinics of North America

5 August 2017

1 reference

5 August 2017

11

1 reference

5 August 2017

2

1 reference

5 August 2017

257-72, viii

1 reference

5 August 2017

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

1 reference

7 January 2021

Molecular biology of esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

A Restriction Point for Control of Normal Animal Cell Proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Control of the cell cycle and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Expression of cyclin E in dysplasia, carcinoma, and nonmalignant lesions of Barrett esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Significance of Fas and retinoblastoma protein expression during the progression of Barrett's metaplasia to adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Clinical significance of retinoblastoma protein (pRB) expression in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

The complexity of p53 modulation: emerging patterns from divergent signals

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Evolution of neoplastic cell lineages in Barrett oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Association between p53 immunostaining and cigarette smoking in squamous cell carcinoma of the esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Abnormal expression of growth regulatory factors in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variables

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Expression of p53, PCNA, and C-erbB-2 in Barrett's metaplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

1 reference

7 January 2021

Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Identification of a phorbol ester-repressible v-src-inducible gene

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

The host-tumor immune conflict: from immunosuppression to resistance and destruction

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

The role of FasL-induced apoptosis in immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Fas ligand and immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Fas ligand expression in esophageal carcinomas and their lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

Decreased expression of Fas (CD95/APO1) associated with goblet cell metaplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2802%2900003-0

7 January 2021

10.1016/S1055-3207(02)00003-0

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12424849